BridgeBio Pharma, Inc.
BBIO
$32.92
$0.732.27%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 155.74% | -40.52% | -13.84% | 19.50% | -19.95% |
Total Receivables | 887.87% | -27.58% | -99.72% | 13,349.11% | -66.13% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | 7.54% | 1.66% | 1.02% | 15.65% | 7.63% |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -97.43% | 6.81% | 106,319.08% | -99.21% | 0.01% |
Total Current Assets | 62.11% | -27.86% | -21.34% | 64.04% | -18.73% |
|
|||||
Total Current Assets | 62.11% | -27.86% | -21.34% | 64.04% | -18.73% |
Net Property, Plant & Equipment | -15.60% | -11.50% | -12.12% | -1.90% | -8.75% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -2.44% | -2.38% | -2.32% | -2.27% | -2.22% |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -10.33% | 7.34% | -8.78% | -1.44% | 15.67% |
Total Assets | 38.25% | -16.29% | -6.47% | 55.45% | -16.58% |
|
|||||
Total Accounts Payable | -28.03% | -26.28% | 283.38% | -55.63% | 138.26% |
Total Accrued Expenses | 18.51% | 16.15% | -17.67% | -6.40% | 37.83% |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -2.04% | -0.50% | 1.74% | 10.08% | -0.22% |
Total Finance Division Other Current Liabilities | -2.16% | -22.92% | -5.50% | 87.91% | -3.94% |
Total Other Current Liabilities | -2.16% | -22.92% | -5.50% | 87.91% | -3.94% |
Total Current Liabilities | 10.91% | 3.61% | -5.03% | -1.65% | 35.62% |
|
|||||
Total Current Liabilities | 10.91% | 3.61% | -5.03% | -1.65% | 35.62% |
Long-Term Debt | 0.12% | 0.10% | 0.10% | -0.63% | 0.33% |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | -19.49% | -17.37% | -14.92% | -7.62% | -8.47% |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 2,512.46% | 8.93% | -14.84% | 118.83% | -20.57% |
Total Liabilities | 26.21% | 0.37% | -0.52% | -0.14% | 2.17% |
|
|||||
Common Stock & APIC | 1.44% | 1.35% | 1.65% | 22.95% | 1.47% |
Retained Earnings | -9.36% | -6.07% | -2.83% | -1.38% | -7.03% |
Treasury Stock & Other | 0.00% | 0.00% | 0.00% | -0.01% | 0.00% |
Total Common Equity | -19.35% | -12.53% | -4.13% | 22.50% | -12.15% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -19.35% | -12.53% | -4.13% | 22.50% | -12.15% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -10.74% | 6.44% | -14.51% | 8.09% | -15.11% |
Total Equity | -19.63% | -12.60% | -4.36% | 22.77% | -12.47% |
|